Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 3/20 | 0.47 |
| ▸ | P2RY6 | Q15077 | 5/20 | 0.35 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.34 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.34 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.34 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.34 |
| ▸ | P2RY2 | P41231 | 6/20 | 0.33 |
| ▸ | P2RY14 | Q15391 | 3/20 | 0.33 |
| ▸ | P2RY4 | P51582 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21418938 | 0.89 | DUT (0.48) | DUTP2RY6SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL17512784 | 0.87 | DUT (0.44) | DUTP2RY6SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL17512782 | 0.87 | DUT (0.44) | DUTP2RY6SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL21124015 | 0.87 | DUT (0.44) | DUTP2RY6SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL21124484 | 0.87 | DUT (0.46) | DUTP2RY6SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL17512832 | 0.87 | DUT (0.46) | DUTP2RY6SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL17512834 | 0.87 | DUT (0.46) | DUTP2RY6SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL21124013 | 0.87 | DUT (0.46) | DUTP2RY6SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL17512770 | 0.87 | DUT (0.46) | DUTP2RY6SLC28A1SLC28A2SLC29A1 | |
| SCHEMBL17512774 | 0.87 | DUT (0.46) | DUTP2RY6SLC28A1SLC28A2SLC29A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200157137-A1 | 2'-CHLORO AMINOPYRIMIDINONE AND PYRIMIDINE DIONE NUCLEOSIDES | GILEAD SCIENCES, INC. | 2020-05-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200157137-A1 | 2'-CHLORO AMINOPYRIMIDINONE AND PYRIMIDINE DIONE NUCLEOSIDES | TYMP, DPYD, TYMS | DUT 13/4885P2RY6 842/4885SLC28A1 131/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.